Select for export The hidden therapist: evidence for a central role of music in psychedelic therapy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-017-4820-5 PubMed 29396616 Copy citation Copy BibTeX Psychopharmacology 2018-02-01 Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N Europe PMC Published psilocybin DepressionAddictionEmotional Processing Other More
Select for export Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2017.00974 PubMed 29387009 Copy citation Copy BibTeX Frontiers in Pharmacology 2018-01-16 Roseman L, Nutt DJ, Carhart-Harris RL. Europe PMC Published psilocybin DepressionAnxietyConsciousness Clinical Trial More
Select for export Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881117748902 PubMed 29338538 Copy citation Copy BibTeX Journal of Psychopharmacology 2018-01-16 Lyons T, Carhart-Harris RL. Europe PMC Published psilocybin DepressionPersonality ChangeObservational Study Observational Study More
Select for export Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-017-4807-2 PubMed 29302713 Copy citation Copy BibTeX Psychopharmacology 2018-01-04 Bravermanová A, Viktorinová M, Tylš F, Novák T, Androvičová R, Korčák J Europe PMC Published psilocybinpsilocin Receptor PharmacologyBiomarkersHealthy Volunteers Other More
Select for export Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2017.12.041 PubMed 29288686 Copy citation Copy BibTeX Neuropharmacology 2017-12-26 Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL. Europe PMC Published psilocybin DepressionBrain ImagingAging Other More
Select for export LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2017.00814 PubMed 29167644 Copy citation Copy BibTeX Frontiers in Pharmacology 2017-11-07 Kraehenmann R, Pokorny D, Aicher H, Preller KH, Pokorny T, Bosch OG Europe PMC Published psilocybin Receptor PharmacologyConsciousness Other More
Select for export Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-017-4771-x PubMed 29119217 Copy citation Copy BibTeX Psychopharmacology 2017-11-07 Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE Europe PMC Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-017-4769-4 PubMed 29116367 Copy citation Copy BibTeX Psychopharmacology 2017-11-06 Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR. Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyMystical Experience Observational Study More
Select for export Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-017-4754-y PubMed 29085980 Copy citation Copy BibTeX Psychopharmacology 2017-10-29 Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ Europe PMC Published psilocybin DepressionEmotional ProcessingTreatment-Resistant Depression Other More
Select for export The relationships of classic psychedelic use with criminal behavior in the United States adult population. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881117735685 PubMed 29039233 Copy citation Copy BibTeX Journal of Psychopharmacology 2017-10-16 Hendricks PS, Crawford MS, Cropsey KL, Copes H, Sweat NW, Walsh Z Europe PMC Published psilocybin Observational StudyAdolescents Observational Study More
Select for export Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881117731279 PubMed 29020861 Copy citation Copy BibTeX Journal of Psychopharmacology 2017-10-10 Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA Europe PMC Published psilocybin WellbeingSpiritualityMystical Experience Clinical Trial More
Select for export Effect of Psilocybin on Empathy and Moral Decision-Making. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyx047 PubMed 28637246 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2017-08-31 Pokorny T, Preller KH, Kometer M, Dziobek I, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyEmotional ProcessingHealthy Volunteers Other More
Select for export Psychedelic Drugs as Therapeutics: No Illusions About the Challenges. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.776 PubMed 28836272 Copy citation Copy BibTeX Clinical Pharmacology & Therapeutics 2017-08-23 Sellers EM, Leiderman DB. Europe PMC Published psilocybin Safety Other More
Select for export Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881117714049 PubMed 28631526 Copy citation Copy BibTeX Journal of Psychopharmacology 2017-06-19 Forstmann M, Sagioglou C. Europe PMC Published psilocybin AddictionWellbeingPersonality Change Observational Study More
Select for export Psilocybin: Good Trip or Bad Trip. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.697 PubMed 28548221 Copy citation Copy BibTeX Clinical Pharmacology & Therapeutics 2017-05-25 Sellers EM. Europe PMC Published psilocybin Pharmacology Other More
Select for export An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116684335 PubMed 28095732 Copy citation Copy BibTeX Journal of Psychopharmacology 2017-01-17 Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. Europe PMC Published psilocybin DepressionAddictionMechanism of Action Observational Study More
Select for export Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116675512 PubMed 27909164 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-30 Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116675513 PubMed 27909165 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-30 Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116678781 PubMed 27856683 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-16 Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. Europe PMC Published psilocybin DepressionAnxietyConsciousness Case Report More
Select for export Role of psilocybin in the treatment of depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125316676092 PubMed 28101325 Copy citation Copy BibTeX Therapeutic Advances in Psychopharmacology 2016-10-26 Mahapatra A, Gupta R. Europe PMC Published psilocybin DepressionAnxietyReceptor Pharmacology Other More
